Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of small-molecule HSF1 amplifiers by high content screening in protection of cells from stress induced injury.

Biochemical and biophysical research communications·2009
Same author

Nanowire transformation by size-dependent cation exchange reactions.

Nano letters·2009
Same author

Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial.

Journal of alternative and complementary medicine (New York, N.Y.)·2009
Same author

Identification of inhibitors of HSF1 functional activity by high-content target-based screening.

Journal of biomolecular screening·2009
Same author

Antitumor effects of targeting hTERT lentivirus-mediated RNA interference against KB cell lines.

Oncology research·2009
Same author

Characteristics of emissive spectrum and the removal of nitric oxide in N2/02/NO plasma with argon additive.

Journal of environmental sciences (China)·2009

Related Experiment Video

Updated: Dec 15, 2025

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

11.6K

Brain Proteomic Profiling in Intractable Epilepsy Caused by TSC1 Truncating Mutations: A Small Sample Study.

Yi-Dan Liu1, Meng-Yu Ma1, Xi-Bin Hu2

  • 1Cheeloo College of Medicine, Shandong University, Jinan, China.

Frontiers in Neurology
|July 14, 2020
PubMed
Summary

Tuberous sclerosis complex (TSC) patients with intractable epilepsy show altered brain protein expression. This study identified specific protein changes in the brain linked to TSC1 mutations, offering insights into disease mechanisms.

Keywords:
TSC1 geneepilepsymutationproteomic profilingtuberous sclerosis complex

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.1K

Related Experiment Videos

Last Updated: Dec 15, 2025

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

11.6K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.1K

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder.
  • TSC causes various abnormalities, including refractory epilepsy (TRE), affecting over half of patients.
  • TSC1 truncating mutations are a known cause of intractable epilepsy in TSC.

Purpose of the Study:

  • To investigate protein expression changes in the brain of patients with TSC1 truncating mutations and intractable epilepsy.
  • To identify potential molecular mechanisms underlying brain damage in TSC-related epilepsy.
  • To compare protein profiles between diseased TSC brain tissue and control brain tissue.

Main Methods:

  • Collected brain tissue from three TSC patients with TSC1 truncating mutations and three control subjects.
  • Utilized data-independent acquisition (DIA) workflow for protein spectrum detection.
  • Performed bioinformatics analysis on differentially expressed proteins.

Main Results:

  • Identified 55 up-regulated and 55 down-regulated proteins in TSC brain tissue compared to controls.
  • Found that differentially expressed proteins are predominantly located in the synaptic membrane.
  • Observed potential impact of TSC1 truncating mutations on amino acid metabolism pathways.

Conclusions:

  • TSC1 truncating mutations lead to significant alterations in brain protein expression, particularly at the synaptic membrane.
  • These protein changes may contribute to the pathogenesis of intractable epilepsy in TSC.
  • The study provides a novel perspective on understanding the brain damage mechanisms in TSC.